estudo mirasol: análises dos dados de mirvetuximabe soravtansina em pacientes com câncer de ovário
Published 1 year ago • 196 plays • Length 4:52Download video MP4
Download video MP3
Similar videos
-
1:50
an overview of a study exploring mirvetuximab soravtansine in ovarian cancer
-
4:40
asco 2023 highlights on the mirasol trial in pt-resistant adv. high-grade epithelial ovarian cancer
-
2:16
dr. matulonis discusses mirvetuximab soravtansine plus pembrolizumab in ovarian cancer
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
0:59
dr secord on mirvetuximab soravtansine in platinum-sensitive, frα-high ovarian cancer
-
18:59
mirvetuximab soravtansine: the soraya & mirasol studies. the future of targeting frα
-
1:59
dr. english on mirvetuximab soravtansine in ovarian cancer
-
4:00
mirvetuximab soravtansine shows promise in frα-positive, platinum-sensitive ovarian cancer
-
1:27
dr. gilbert on evaluating mirvetuximab soravtansine in platinum-agnostic ovarian cancer
-
0:26
copy of dr. english on mirvetuximab soravtansine in ovarian cancer
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer
-
1:41
dr. moore on benefit of mirvetuximab soravtansine in patients with ovarian cancer
-
12:52
asco23 - lba5507: phase iii mirasol (gog 3045/engot-ov55) study (ovarian cancer)
-
2:28
dr. moore on the role of mirvetuximab soravtansine in ovarian cancer
-
1:37
dr. zhang on the imvigor130 trial in metastatic urothelial cancer
-
4:11
treatment options for newly diagnosed aml: venetoclax and midostaurin - blood cancer onctalk
-
1:48
ovarian cancer risk assessment for women with pelvic masses with ovasuitesm
-
4:46
#esmo19: forward i (gog 3011) study for platinum-resistant ovarian cancer
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc